Frequently Asked Questions
Here, we’ve answered some of the most common queries from owners, breeders, and racing enthusiasts about our services, approach, and commitment to excellence in the bloodstock industry. Whether you are exploring your first thoroughbred purchase, seeking expert advice on pedigree selection, or looking to enhance the value of your racing and breeding portfolio, our team is dedicated to delivering transparency, integrity, and exceptional results at every stage.
-
Equity in the mare and proceeds from progeny sales subject to your percentage ownership.
-
80 (1.25%) shares per horse, starting at £5,000 per share
-
5 years, extendable if beneficial for all parties.
-
Board, veterinary care, farrier, insurance, stud fee, foal registration, sales prep, and management fee.
-
By Opulence Bloodstock using statistical analysis, pedigree compatibility, and market trends.
-
Pro-rata within 60 working days of sale completion.
-
Returns are tax-free under current UK rules for recreational investors. Professional advice recommended.
-
Mortality of the mare and mortality of the progeny.
-
Yes, via secondary transfer or Opulence Bloodstock may offer a buyout option.
If you have any further questions that may help with your purchase, please reach out to a member of our fantastic team and we’d be happy to answer any and all questions you may have
The risks
Thoroughbred breeding offers significant return potential, but similar to high performing investments, it can carry some risks. At Opulence Thoroughbreds, we manage these risks proactively to protect your investment and maximise potential returns.
Biological Risk (infertility, foaling complications, injury): Mitigated through rigorous veterinary due diligence, selective acquisition of proven broodmare lines, expert stallion matching, and insurance cover for mortality.
Market Risk (pricing swings, sales cycles, buyer demand): Managed with data-driven mating choices, alignment with commercially proven sire lines, and continuous monitoring of domestic and international sales trends.
Execution Risk (sale timing, preparation, presentation): Controlled through structured development programmes, strategic placement at leading sales, and making strategic hold-or-sell decisions.
Our focus is not simply on breeding quality bloodstock, but on managing the full risk profile of the investment, protecting capital while positioning each opportunity for optimal commercial return.
If you’d like to know more about the risks involved or put your mind to rest, please contact our fantastic team and we’d be happy to answer any further questions.
